Kirby Benjamin J, Poeran Jashvant, Zubizarreta Nicole, London Daniel A
University of Missouri Department of Surgery, 1 Hospital Dr. Columbia, MO 65212, USA.
Department of Population Health, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029 USA.
Surg Pract Sci. 2024 Sep 4;19:100259. doi: 10.1016/j.sipas.2024.100259. eCollection 2024 Dec.
Recent studies demonstrate a link between corticosteroid injection and surgical complications when procedures occur shortly after steroid administration. These publications focus on single procedures like carpal tunnel release. This study seeks to demonstrate how surgical site infection risk changes across thirteen common elective hand procedures when steroid injection is performed contemporaneously.
The Truven MarketScan® database identified patients who had undergone elective hand surgery between 2015 and 2016. Two cohorts were created based on the administration, or absence thereof, of contemporaneous corticosteroid injection. The primary outcome measure was infection within 30 days of surgery as measured by antibiotic prescription or repeat surgical intervention. Multivariate logistic regression was performed to assess the association between concomitant corticosteroid injections and post-operative infections while controlling for demographics and comorbidities.
149,689 patients underwent elective hand surgery. 6104 (4.1 %) received concomitant corticosteroid injection and 14,070 (9.4 %) received post-operative antibiotics or underwent secondary surgical intervention for infection. Treatment for post-operative infection was significantly higher in the corticosteroid group (10.2 % versus 9.3 %; = 0.02) driven by difference in severe infection requiring surgical intervention (3.7 % versus 3.1 %; = 0.03). This finding persisted when controlling for demographics and comorbidities with adjusted OR of 1.10 (CI 1.01-1.20) for all infections and 1.16 (CI 1.01-1.33) for severe infections.
These results support prior findings that patients undergoing concurrent steroid injections and surgery have increased rates of infectious complications though the absolute risk remains small. Limitations of the database preclude further investigation into the details of each procedure (e.g. ipsilateral vs contralateral injection, peri-operative antibiotics) which may impact infection rates.
Concomitant steroid injection with elective hand surgery may increase the risk of postoperative infection, particularly severe infection. However, that relative increase lies between 1 and 33 percent and should be weighed against the benefit from intraoperative corticosteroid administration.
近期研究表明,在使用皮质类固醇后不久进行手术时,皮质类固醇注射与手术并发症之间存在关联。这些出版物聚焦于诸如腕管松解术等单一手术。本研究旨在证明在同时进行皮质类固醇注射的情况下,13种常见的择期手部手术的手术部位感染风险如何变化。
Truven MarketScan®数据库确定了2015年至2016年间接受择期手部手术的患者。根据是否同时进行皮质类固醇注射创建了两个队列。主要结局指标是术后30天内的感染情况,通过抗生素处方或再次手术干预来衡量。进行多变量逻辑回归以评估同时进行皮质类固醇注射与术后感染之间的关联,同时控制人口统计学和合并症因素。
149,689例患者接受了择期手部手术。6104例(4.1%)同时接受了皮质类固醇注射,14,070例(9.4%)接受了术后抗生素治疗或因感染接受了二次手术干预。皮质类固醇组术后感染的治疗率显著更高(10.2%对9.3%;P = 0.02),这是由需要手术干预的严重感染差异所致(3.7%对3.1%;P = 0.03)。在控制人口统计学和合并症因素后,这一发现仍然存在,所有感染的调整后比值比为1.10(95%置信区间1.01 - 1.20),严重感染的调整后比值比为1.16(95%置信区间1.01 - 1.33)。
这些结果支持了先前的研究发现,即同时接受类固醇注射和手术的患者感染并发症发生率增加,尽管绝对风险仍然较小。数据库的局限性使得无法进一步调查可能影响感染率的每个手术细节(例如同侧与对侧注射、围手术期抗生素使用情况)。
择期手部手术同时进行类固醇注射可能会增加术后感染风险,尤其是严重感染风险。然而,相对增加幅度在1%至33%之间,应与术中使用皮质类固醇的益处相权衡。